Skip to main content
Livermore
Livermore
ZHEN

Abner Herrman & Brock LLC

SEC CIK
0001038661
Latest filing
Jul 8, 2026

BCLI holding history

Brainstorm Cell Therapeutics Inc. in every 13F filed by Abner Herrman & Brock LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCLI overviewAll 13F holders of BCLIFull Q2 2026 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
15
Since Q1 2021
Holdings of BCLI by Abner Herrman & Brock LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−9,700−100.0%Sold outConverted for a 1-for-15 splitHolders
Q3 2024145,500$34.0K<0.1%00.0%UnchangedHolders
Q2 2024145,500$49.0K<0.1%00.0%UnchangedHolders
Q1 2024145,500$82.0K<0.1%00.0%UnchangedHolders
Q4 2023145,500$40.0K<0.1%00.0%UnchangedHolders
Q3 2023145,500$29.0K<0.1%−134,500−48.0%ReducedHolders
Q2 2023280,000$577.0K0.1%00.0%UnchangedHolders
Q1 2023280,000$924.0K0.1%00.0%UnchangedHolders
Q4 2022280,000$459.0K0.1%00.0%UnchangedHolders
Q3 2022280,000$1.24M0.2%+15,000+5.7%AddedHolders
Q2 2022265,000$731.0K0.1%00.0%UnchangedHolders
Q1 2022265,000$890.0K0.1%+32,000+13.7%AddedHolders
Q4 2021233,000$932.0K0.1%+28,000+13.7%AddedHolders
Q3 2021205,000$676.0K0.1%−36,500−15.1%ReducedHolders
Q2 2021241,500$918.0K0.1%00.0%UnchangedHolders
Q1 2021241,500$925.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.